HLK at LSPN North America Fall 2024

We’re looking forward to the upcoming LSPN North America Fall 2024 conference, that’s taking place in San Francisco in October.

Now in its sixth year, the theme for this year’s conference is ‘protecting and leveraging your IP across the life cycle of innovation’. The programme will deliver an overview of the latest rulings and legislative developments, as well as providing a platform for professionals to share their solutions to everyday IP challenges.

We’re proud to sponsor this event and help bring together in-house patent counsel from leading pharmaceutical and biotechnology companies.

Date: 15 – 16 October 2024
Location: San Francisco, USA

On the conference agenda

Roundtable: Strategies for protecting CRISPR, CAR-T and other immunotherapies

We’re hosting a roundtable on Day 2 of the conference, focusing on strategies for protecting CRISPR, CAR-T and other immunotherapies.

Time: 11:20-12:55 (EDT)
Date: Wednesday 16 October 2024

Meet the HLK team attending LSPN North America Fall 2024

At HLK, we enjoy developing long-standing, collaborative relationships, and aim to understand our client’s business needs. Our team has a wealth of experience across the IP lifecycle in the pharma and life sciences field.

Meet our experts who’ll be at the conference.

Joseph Lenthall

Partner | UK and European Patent Attorney | UPC Representative

Joe is a leading Chemistry & Life Sciences EPO Opposition and Appeal specialist. He is particularly adept at handling complex multi-party Oppositions and Appeals. Recent highlights include defending EP patents covering small molecule splicing modulator therapies, CRISPR gene-editing therapies, protein kinase inhibitors, companion diagnostics, ADCs, thin film drug delivery technology, and foods incorporating recombinant proteins.

Joe’s opposition practice feeds back into the team’s drafting and prosecution practice to ensure robust patent protection for commercially significant products. Joe has particular expertise in the fields of therapeutics (including secondary protection through formulations, drug delivery, dosage regimes and patient stratification), diagnostics, biocatalysis and microbial fermentation.

Get in touch

Catherine Coombes

Partner | UK and European Patent Attorney

A CRISPR specialist, Cath has worked on some of the earliest CRISPR patents exploiting its role in bacterial immunity and has been at the forefront on this technology ever since. As such, Cath has extensive experience in opposition matters, due diligence, and drafting across the wide array of technologies to which CRISPR has been applied. Cath has provided education to fellow patent attorneys, has written numerous articles and has provided commentary on CRISPR IP to leading scientific and IP journals such as Nature, Science, The Scientist, IAM and LSIPR.

Prior to joining the IP profession Cath’s background was in the scale up of active pharmaceutical ingredients and in the downstream processing of food ingredients.

Get in touch

Caroline Day

Partner | UK and European Patent Attorney

As a speaker at a variety of high-profile seminars and author of numerous articles, Caroline is a leading expert in the field of protecting Artificial Intelligence (AI) and Machine Learning. Caroline’s professionalism, pragmatism, and solutions-oriented approach means that she earns the deep trust from her clients and maintains many long-standing relationships with a number of global businesses. Thanks to time spent working in-house in the past, Caroline developed a strong understanding of the strategic and operational challenges faced by in-house counsel and is uniquely placed to help solve those challenges.

Get in touch

Insights from our team

Read the most recent insights from our team.

Webinar - Navigating life sciences and pharma patentability pitfalls: Definitions and clinical trials

What are the pitfalls when it comes to navigating life sciences and pharma patents? Our experts will be exploring definitions and clinical trials in our upcoming webinar on Wednesday 30 October to help you avoid those stumbling blocks.

Register now

On-demand webinar - Changes to patenting life sciences and medical innovation in Europe

Our Life Sciences and Healthcare team have delved into the recent valuable changes and updates relevant to patenting life sciences, healthcare and medical innovations in Europe.

Watch recording

EPO reconsiders meaning of “substance or composition” for medical use claims

In this article, we explore the evolving definition of ‘substance or composition’ in European patent law, with a focus on medical use claims, and the recent EPO decision T 1252/20, challenging established norms and its implications for patenting materials in biomedical innovation.

Read more

Pharmaceutical clinical trials and patentability at the EPO

From protecting active pharmaceutical ingredients to novel dosage regimes and patient sub-populations, this article delves into European Patent Office case law on patentability during clinical trials.

Read more

The UPC Court of Appeal’s first decision: What does it mean for the assessment of inventive step at the UPC?

A deep dive article on the Unified Patent Court of Appeal’s decision on 10X Genomics’ application for a preliminary injunction.

Read the article.

Transatlantic Toolkit

Our collection of quick tips and suggestions for patenting across the pond, dedicated to helping US patent attorneys navigate UK and European patents.

Read more

Open box with letters of the alphabet emerging

Unified Patent Court

With expert European Patent Attorneys in every major technical discipline and an in-house litigation team including Patent Attorney Litigators able to represent clients at the UPC, we’re uniquely placed to help our clients to navigate the complexities of the new system which came into effect on 1 June 2023.

Find out more

Artificial Intelligence

The rapid rise in the use of AI tools in businesses is an exciting development but it brings with it uncertainty and risk. Our AI law and regulation team help businesses to manage these risks from both a legal and regulatory perspective.

Find out more

Trade Marks

With expertise in protection strategies as well as contentious proceedings, we can support all of the stages of the life span of your trade marks, calling on the support of our legal team when necessary.

Meet the team